Abstract
Diabetes affects approximately 450 million adults globally. If not effectively managed, chronic hyperglycaemia causes tissue damage that can develop into fibrosis. Fibrosis leads to end-organ complications, failure of organ systems occurs, which can ultimately cause death. One strategy to tackle end-organ complications is to maintain normoglycaemia. Conventionally, insulin is administered subcutaneously. Whilst effective, this delivery route shows several limitations, including pain. The transdermal route is a favourable alternative. Microneedle (MN) arrays are minimally invasive and painless devices that can enhance transdermal drug delivery. Convincing evidence is provided on MN-mediated insulin delivery. MN arrays can also be used as a diagnostic tool and monitor glucose levels. Furthermore, sophisticated MN array-based systems that integrate glucose monitoring and drug delivery into a single device have been designed. Therefore, MN technology has potential to revolutionise diabetes management. This review describes the current applications of MN technology for diabetes management and how these could prevent diabetes induced fibrosis.
Original language | English |
---|---|
Article number | 113825 |
Number of pages | 29 |
Journal | Advanced Drug Delivery Reviews |
Volume | 175 |
Early online date | 17 Jun 2021 |
DOIs | |
Publication status | Published - Aug 2021 |
Keywords
- Diabetes
- End-organ complications
- Microneedle-mediated transdermal delivery
- Minimally invasive devices
- Insulin delivery systems
- Glucose monitoring
- Interstitial fluid
Fingerprint
Dive into the research topics of 'The role of microneedle arrays in drug delivery and patient monitoring to prevent diabetes induced fibrosis'. Together they form a unique fingerprint.Student theses
-
Microarray patches for the delivery of the poorly soluble drug olanzapine
McKenna, P. (Author), Donnelly, R. (Supervisor), Larraneta Landa, E. (Supervisor) & Kearney, M.-C. (Supervisor), Jul 2022Student thesis: Doctoral Thesis › Doctor of Philosophy
-
Transdermal delivery of heavy chain only antibody binding domains using hydrogel-forming microarray patches
Hutton, A. (Author), Donnelly, R. (Supervisor) & Scott, C. (Supervisor), Jul 2022Student thesis: Doctoral Thesis › Doctor of Philosophy